Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood

  • Helen F. Cross
  • , Melang Haarbrink
  • , Gill Egerton
  • , Maria Yazdanbakhsh
  • , Mark Taylor

Research output: Contribution to journalArticlepeer-review

122 Citations (Scopus)

Abstract

Wolbachia bacteria seem to have evolved as essential endosymbionts of their filarial nematode hosts. Studies in mice have suggested that these bacteria are associated with systemic inflammatory reactions to filarial chemotherapy. We took blood samples from 15 Indonesian patients before and after treatment with diethylcarbamazine for Brugia malayi infection, and recorded the severity of any post-treatment inflammatory reactions. Blood from all three patients with severe adverse reactions and from one of six with moderate reactions was positive for Wolbachia DNA 4-48 h after diethylcarbamazine treatment. We suggest that these severe inflammatory reactions are associated with the release of endosymbionts into the blood after treatment for filariasis.
Original languageEnglish
Pages (from-to)1873-1875
Number of pages3
JournalThe Lancet
Volume358
Issue number9296
DOIs
Publication statusPublished - 1 Dec 2001

Fingerprint

Dive into the research topics of 'Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood'. Together they form a unique fingerprint.

Cite this